Lupin Limited is a global pharmaceutical company, with products distributed in over 100 markets. The Company specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients (API). It operates predominantly in India and the United States across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. It has a presence in the cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments and also operates in the anti-TB and cephalosporins segments. Its generic formulations include Filgrastim, Pegfilgrastim, Etanercept and Albuterol, among others. Its diabetes brands include Gibtulio, Ajaduo, Gibtulio Met, ONDERO and ONDERO MET. Its other brands include AntaGolin and RyChol, among others.